Cita APA

Agache, I., Beltran, J., Akdis, C., Akdis, M., Canelo-Aybar, C., Canonica, G., . . . Jutel, M. (2020). Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma.

Citación estilo Chicago

Agache, I., et al. Efficacy and Safety of Treatment With Biologicals (benralizumab, Dupilumab, Mepolizumab, Omalizumab and Reslizumab) for Severe Eosinophilic Asthma. 2020.

Cita MLA

Agache, I., et al. Efficacy and Safety of Treatment With Biologicals (benralizumab, Dupilumab, Mepolizumab, Omalizumab and Reslizumab) for Severe Eosinophilic Asthma. 2020.